-The Indian Express Aadya died of dengue at the hospital in September, and her family was charged almost Rs 16 lakh for a 15-day stay. New Delhi: Fortis Hospital, Gurgaon made a 1,737 per cent profit on drugs and other consumables that it billed the family of seven-year-old Aadya Singh, the drug pricing regulator has found in an analysis. Aadya died of dengue at the hospital in September, and her family was charged...

-The Economic Times Max Super Specialty, Patparganj has made “unfair” and “excessive” profits on the sale of disposable syringes to patients admitted in its hospital, an investigation by the Competition Commission of India has revealed. The commission is expected to hold a hearing on this issue on December 20. CCI in 2015 ordered a probe into allegations that the hospital had colluded with multinational syringe maker Becton Dickinson’s Indian arm to sell...

-The Hindu Business Line Public procurement at a negotiated price is a better option. Price curbs deter producers and don’t check pharmacy margins The Government’s attempt to keep the prices of essential medicines affordable and curb the extraordinary returns earned by private healthcare providers through price controls has started an inexorable process whose end does not seem in sight. Will these moves eventually be counter-productive? First came the move to extend the scope...

-The Telegraph New Delhi: Doctors who receive gifts from pharmaceutical companies are more likely to prescribe expensive versions of medicines and more drugs per patient, a US study released on Wednesday suggested. The study is among the first to quantitatively measure the impacts of such gifts and challenges claims by sections of pharmaceutical industry executives that industry gifts are not intended to influence prescriptions doctors write. Health policy researchers who analysed prescription patterns...

-The Times of India and other agencies WASHINGTON: United States President Donald Trump has promised to bring the cost of prescription drugs in the country "way down" and let other countries pay more for these medicines. If effected, Trump's new policy on prescription drugs, dicussed with his cabinet at the White House on Monday, could have grave implications for India. The US has long had a grouse with India over its patent...